Skip to content

Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy

Influence of Meditation-Based Breathing Training on Target Motion Management and Distress During Radiation for Abdominal and Lung Malignancies

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01939210
Enrollment
17
Registered
2013-09-11
Start date
2010-02-28
Completion date
2015-12-02
Last updated
2018-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Digestive System Neoplasm, Lung Neoplasm, Pain, Post-Traumatic Stress Disorder, Psychological Impact of Cancer

Brief summary

This randomized pilot clinical trial studies the effects of meditation-based breathing training on patients' control of their breathing patterns and breathing-related movement, as well as on their psychological distress and treatment experience during radiation therapy. Meditation-based breathing training may decrease breathing-related movement and the amount of stress by improving breathing patterns in patients with abdominal or lung cancer undergoing radiation therapy.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the influence of regular breathing cycles using breathing relaxation techniques on efficacy of the respiratory-gated treatment as measured by: (1) real-time position management (RPM) parameters; (2) end inspiration or expiration length; (3) changes in gate width. SECONDARY OBJECTIVES: I. To evaluate the effect of breathing relaxation techniques on: (1) psychosocial outcomes; (2) treatment compliance. OUTLINE: PHASE I: Patients and staff members complete structured interviews at baseline. PHASE II: Patients are randomized to 1 of 2 arms. ARM I: Patients participate in 3 50-minute breathing training sessions, including a psycho-educational component and meditation-based breathing training, over 10 days. Patients then undergo four dimensional computed tomography (4D-CT) on day 14 and undergo image-guided stereotactic body radiation therapy (SBRT) or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively. ARM II: Patients receive standard care over 10 days. Patients then undergo 4D-CT on day 14 and undergo image-guided SBRT or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively. After completion of study treatment, patients are followed up at 2 or 5 weeks.

Interventions

OTHEREducational Intervention

Participate in breathing training sessions

Participate in breathing training sessions

OTHERQuestionnaire Administration

Ancillary studies

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Albert Einstein College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* PHASE I - PATIENTS: All patients with abdominal tumors who have undergone at least 4 respiratory-gated radiotherapy treatments * PHASE I - PATIENTS: Full comprehension of English language * PHASE I - STAFF: All staff who have overseen the delivery of respiratory-gated radiotherapy for at least 6 months * PHASE I - STAFF: Full comprehension of English language * PHASE II: All patients with abdominal or lung tumors undergoing a respiratory gating simulation * PHASE II: Karnofsky performance status \> 60% * PHASE II: Life expectancy \> 3 months * PHASE II: No prior radiotherapy to the abdomen/lung * PHASE II: Full comprehension of English language

Exclusion criteria

* PHASE I - PATIENTS: Inability to comprehend English language interview questions * PHASE I - STAFF: Inability to comprehend English language interview questions * PHASE II: Karnofsky performance status \< 60% * PHASE II: Prior radiotherapy to the abdomen/lung * PHASE II: Evidence of progressive or untreated gross disease outside of the abdomen/lung * PHASE II: Inability to comprehend English language breathing exercise instructions * PHASE II: Concurrent diagnosis of a significant respiratory disorder which requires the use of oxygen

Design outcomes

Primary

MeasureTime frameDescription
Change in duty cycle, defined as the fraction of the time of the breathing cycle that the beam is on, before and after breath coachingBaseline to up to 5 weeksData will be analyzed using a mixed-model analysis of variance (ANOVA) to test for differences between the two independent groups (with a fixed effect factor of group membership).
Changes in gate widthBaseline to up to 5 weeks
Changes in the length of the end expiration or end inspiration defined as when the breathing trace or internal motion change directionBaseline to up to 5 weeksData will be analyzed using a mixed-model ANOVA to test for differences between the two independent groups (with a fixed effect factor of group membership).

Secondary

MeasureTime frameDescription
Change in patients' self-reported levels of psychological distress, physical pain and discomfort, and post-traumatic stress associated with cancer diagnosis and radiation treatmentBaseline to up to 5 weeksData will be analyzed using a mixed-model ANOVA to test for differences between the two independent groups (with a fixed effect factor of group membership).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026